Additional file 1 of Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports
| Autor: | Enzing, Joost J., Knies, Saskia, Engel, Jop, IJzerman, Maarten J., Sander, Beate, Vreman, Rick, Boer, Bert, Brouwer, Werner B. F. |
|---|---|
| Rok vydání: | 2022 |
| DOI: | 10.6084/m9.figshare.20761514.v1 |
| Popis: | Additional file 1: Table S1. References to the HTA-reports on cancer drugs included in the analysis (n = 66). Table S2. References to the included HTA-reports related to the cases on orphan pharmaceuticals (n = 21). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|